Test results after stem cell transplant for multiple myeloma can confuse patients and doctors about cancer's status
That is Dr. Gurmukh Singh, vice chair of scientific affairs for the Division of Pathology and Walter L. Shepeard Chair in Scientific Pathology on the Medical School of Georgia at Augusta College. Credit score: Phil Jones It is a most cancers of the plasma cells, which usually make an array of antibodies that shield us from an infection. With a number of myeloma, the cells begin primarily producing as a substitute a singular product, known as a monoclonal antibody, or M spike, that leaves sufferers weak for critical infections, like pneumonia, and might even eat away at their bones. Subtle laboratory checks used to each diagnose the illness then comply with remedy response, can ship complicated messages to sufferers and their physicians, significantly after stem cell remedy to attempt to restore a wholesome antibody combine, says Dr. Gurmukh Singh. Singh, vice chair of scientific affairs for the Division of ...